1.
The Primary Research of Outer Membrane Proteins Complex from Serogroup B Neisseria Meningitidis
B群脑膜炎球菌外膜蛋白复合物免疫原性初探
2.
Study on Immunogenicity of Group A and Group C Meningococcal Conjugate Vaccine with Coupling Group B Meningococcal Outer Membrane Protein
B群脑膜炎球菌外膜蛋白偶联A+C群脑膜炎球菌结合疫苗的免疫原性研究
3.
meningococcal meningitis
脑膜炎球菌性脑膜炎
4.
meningococcal arthritis
脑膜炎双球菌性关节炎
5.
meningococcal optic neuritis
脑膜炎球菌性视神经炎
6.
Optimization of Fermentation Procedure for Groups C and W_(135) Neisseria meningococcus
C群和W_(135)群脑膜炎球菌发酵工艺的优化
7.
A bacterium(Neisseria meningitidis)that causes cerebrospinal meningitis.
脑膜炎球菌引起脑脊膜炎症的（脑膜炎奈瑟氏球菌）的细菌
8.
Objective To prepare safe and valid Group A Meningococcal polysaccharide conjugate vaccine.
目的制备安全、效的A群脑膜炎球菌多糖结合疫苗。
9.
MOLECULAR TYPING OF NEISSERIA MENINGITIDIS SEROGROUP B STRAINS WITH PULSED FIELD GEL ELECTROPHORESIS IN SICHUAN
四川省B群脑膜炎奈瑟菌脉冲场凝胶电泳分型分析
10.
Therapeutic Efficiency of Intravenous Amphoteric B-nanoparticles Against Experimental Cryptococcal Meningitis;
纳米载体携载两性霉素B治疗隐球菌性脑膜炎的实验研究
11.
Situation of carrier rate of Neisseria meningitides in school healthy population in Quzhou City during 2003～2008
衢州市2003～2008年学校健康人群脑膜炎球菌带菌状况调查分析
12.
Objective To explore the clinical significance of treatment of cryptococcal meningitis with amphotericin B( AMB) by quantitatively counting cryptococcus neoformans in CSF.
目的探讨隐球菌定量计数法在判断两性霉素B(MB)疗新型隐球菌性脑膜炎的临床意义。
13.
CT and MRI Findings of Cryptococcus Meningoencephalitis
隐球菌性脑膜脑炎的CT和MRI表现
14.
Objective To prepare group A+ C meningococcal polysaccharide conjugate vaccine.
目的研制A+群脑膜炎球菌多糖-破伤风类毒素结合疫苗。
15.
Study on Safety and Immunogenicity of Group A/C Meningococcal Polysaccharide Conjugate Vaccine
A+C群脑膜炎球菌多糖结合疫苗安全性和免疫原性研究
16.
Immediate Adverse Reaction after Mass Vaccination of Groups A+C Meningococcal Polysaccharide Vaccine
A+C群脑膜炎球菌多糖疫苗大规模接种后的速发型接种反应观察
17.
Observation on the safety and immunogenicity of group A+C meningococcal polysaccharide vaccine
冻干A+C群脑膜炎球菌多糖疫苗安全性和免疫原性观察
18.
acute fulminating meningococcemia
急性暴发性脑膜炎球菌血症